Skip to main content
SpringerLink
Log in

Behçet’s Syndrome and Gynecological Manifestation in Reproductive Age and Pregnancy

  • Chapter
  • First Online:
Behçet's Syndrome

Part of the book series: Rare Diseases of the Immune System ((RDIS))

  • 1346 Accesses

Abstract

Behçet’s syndrome (BS) shows characteristic genital ulceration. The endocrine, vascular, and immunological changes that occur in pregnancy produce local modification. BS in pregnancy can be exacerbated and specific lesions can erupt, but generally the disease course is unpredictable and variable from one patient to another. Clinical and therapeutic managements are described below.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Gonçalves O, Valente J (2009) Behçet’s disease-a contemporary review. J Autoimmun 32(3–4):178–188 Epub 2009 Mar 26

    Google Scholar 

  2. Bluthe L (1908) Zur kenntnis des recidiverenden hypopyons. Inaugural Thesis, Heidelberg

    Google Scholar 

  3. Behçet H (1937) Uber rez idivierende, aphthose, durch ein virus verursachte Geschwure am Munde, am Auge und an Genitalien. Dermatol Wochenschr 105:1152–1157

    Google Scholar 

  4. Jadaon J, Shushan A, Ezra Y, Sela HY, Ozcan C, Rojansky N (2005) Behçet’s disease and pregnancy. Acta Obstet Gynecol Scand 84(10):939–944

    PubMed  Google Scholar 

  5. Davatchi F, Shahram F, Davatchi CC, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi AB, Sollahi B (2010) Behçet’s disease: from East to West. Clin Rheumatol 29(8):823–833 Review

    Article  PubMed  Google Scholar 

  6. Zouboulis CC (1999) Epidemiology of Adamantiades-Behçet’s disease. Ann Med Interne 150:488–498

    CAS  Google Scholar 

  7. Al-Otaibi LM, Porter SR, Poate TW (2005) Behçet’s disease: a review. J Dent Res 84(3):209–222 Review

    Article  PubMed  CAS  Google Scholar 

  8. Alpsoy E, Durusoyn C, Yilmaz E, Özgürel Y, Ermis O, Yazar S, Basaran E (2002) Interferon alpha-2a in the treatment of Behçet’s disease: a rando mized, placebo-controlled and double-blind study. Arch Dermatol 138(467):7.1

    Google Scholar 

  9. Chajek T, Fainaru M (1975) Behçet’s disease: report of 41 cases and a review of the literature. Medicine (Baltimore) 54:179–196

    Article  CAS  Google Scholar 

  10. Ghate JV, Jorizzo JL (1999) Behçet’s disease and complex aphtosis. J Am Acad Dermatol 40:1–18

    Article  PubMed  CAS  Google Scholar 

  11. Schreiner DT, Jorizzo JL (1987) Behçet’s disease and complex aphtosis. Dermatol Clin 5:769–778

    PubMed  CAS  Google Scholar 

  12. Kontogiannis V, Powell RJ (2000) Behçet’s disease. Postgrad Med J 76:629–637

    Article  PubMed  CAS  Google Scholar 

  13. Marshall SE (2004) Behçet’s disease. Best Pract Res Clin Rheumatol 18(3):291–311

    PubMed  CAS  Google Scholar 

  14. Arbesfeld SJ, Kurban AK (1988) Behçet’s disease: new perspectives on an enigmatic syndrome. J Am Acad Dermatol 19:767–779

    Article  PubMed  CAS  Google Scholar 

  15. Stratigos AJ, Laskaris G, Stratigos JD (1992) Behçet’s disease. Semin Neurol 12:346–357

    Article  PubMed  CAS  Google Scholar 

  16. Alpsoy E, Zouboulis CC, Ehrlich GE (2007) Mucocutaneous lesions of Behçet’s disease. Yonsei Med J 48(4):573–585 Review

    Article  PubMed  CAS  Google Scholar 

  17. Aktulga E et al (1980) A double blind study of colchicine in Behçet’s disease. Haematologica 65:399–402

    PubMed  CAS  Google Scholar 

  18. Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y, Hamuryudan V, Uysal O, Senocak M, Yazici H (2001) A double-blind trial of colchicine in Behçet’s syndrome. Arthritis Rheum 44(11):2686–2692

    Article  PubMed  CAS  Google Scholar 

  19. Mat C et al (2006) A double-blind trial of depot corticosteroids in Behçet’s syndrome. Rheumatology (Oxford) 45:348–352

    Article  CAS  Google Scholar 

  20. Yazici H, Pazarli H, Barnes CG, Tüzün Y, Ozyazgan Y, Silman A, Serdaroğlu S, Oğuz V, Yurdakul S, Lovatt GE et al (1990) A controlled trial of azathioprine in Behçet’s syndrome. N Engl J Med 322(5):281–285

    Article  PubMed  CAS  Google Scholar 

  21. Jorizzo JL, White WL, Wise CM, Zanolli MD, Sherertz EF (1991) Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet’s disease. J Am Acad Dermatol 24(6 Pt 1):973–978

    Article  PubMed  CAS  Google Scholar 

  22. Avci O, Gürler N, Güneş AT (1997) Efficacy of cyclosporine on mucocutaneous manifestations of Behçet’s disease. J Am Acad Dermatol 36(5 Pt 1):796–797

    Article  PubMed  CAS  Google Scholar 

  23. Masuda K et al (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet’s disease. Lancet 1:1093–1096

    Google Scholar 

  24. Sharquie KE (1984) Suppression of Behçet’s disease with dapsone. Br J Dermatol 110(4):493–494

    Article  PubMed  CAS  Google Scholar 

  25. Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128(6):443–450

    Article  PubMed  CAS  Google Scholar 

  26. Katsantonis J, Seltmann H, Wrobel A, Adler YD, Hornemann S, Orfanos CE et al (2001) Xenobiotic regulation of endothelial intracellular and secreted interleukin-8 induced by serum of patients with Adamantiades–Behçet’s disease. In: Bang D, Lee E-S, Lee S (eds) Behçet’s Disease. Proceedings of the 8th and the 9th international conference on Behçet’s Disease Seoul: library of congress cataloging, pp 236–239

    Google Scholar 

  27. Zouboulis CC, Orfanos CE (1998) Treatment of Adamantiades-Behçet disease with systemic interferon alfa. Arch Dermatol 134(8):1010–1016

    Article  PubMed  CAS  Google Scholar 

  28. Goossens PH, Verburg RJ, Breedveld FC (2001) Remission of Behçet’s syndrome with tumour necrosis factor alpha blocking therapy. Ann Rheum Dis 60(6):637

    Article  PubMed  CAS  Google Scholar 

  29. Robertson LP, Hickling P (2001) Treatment of recalcitrant orogenital ulceration of Behçet’s syndrome with infliximab. Rheumatology (Oxford) 40(4):473–474

    Article  CAS  Google Scholar 

  30. Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL (2001) Treatment of intestinal Behçet’s syndrome with chimeric tumour necrosis factor alpha antibody. Gut 49(5):725–728

    Article  PubMed  CAS  Google Scholar 

  31. Uzun S, Alpsoy E, Durdu M et al (2003) The clinical course of Behçet’s disease in pregnancy: a retrospective analysis and review of the literature. J Dermatol 30:499–502

    PubMed  Google Scholar 

  32. Bang D, Chun YS, Haam IB et al (1997) The influence of pregnancy on Behçet’s disease. Yonsei Med J 38:437–443

    PubMed  CAS  Google Scholar 

  33. Noel N, Wechsler B, Nizard J, Chalumeau NC, Boutin LD, Dommergues M, Brouzes DV, Cacoub P, Saadoun D (2013) Behcet’s disease and pregnancy. Arthritis Rheumatol

    Google Scholar 

  34. Seo P (2007) Pregnancy and vasculitis. Rheum Dis Clin North Am 33(2):299–317 Review

    Article  PubMed  Google Scholar 

  35. Torgerson RR, Marnach ML, Bruce AJ, Rogers RS (2006) Oral and vulvar changes in pregnancy. Clin Dermatol 24(2):122–132

    Google Scholar 

  36. Wechsler B, Généreau T, Biousse V, Brouzes DV, Seebacher J, Dormont D, Godeau P (1995) Pregnancy complicated by cerebral venous thrombosis in Behçet’s disease. Am J Obstet Gynecol 173(5):1627–1629

    Article  PubMed  CAS  Google Scholar 

  37. Komaba H, Takeda Y, Fukagawa M (2007) Extensive deep vein thrombosis in a postpartum woman with Behçet’s disease associated with nephrotic syndrome. Kidney Int 71(1):6

    Article  PubMed  CAS  Google Scholar 

  38. Hiwarkar P, Stasi R, Sutherland G, Shannon M (2010) Deep vein and intracardiac thrombosis during the post-partum period in Behçet’s disease. Int J Hematol 91(4):679–686

    Article  PubMed  Google Scholar 

  39. Hwang I, Lee CK, Yoo B, Lee I (2009) Necrotizing villitis and decidual vasculitis in the placentas of mothers with Behçet disease. Hum Pathol 40(1):135–138

    Article  PubMed  Google Scholar 

  40. Whitacre CC, Reingold SC, O’Loorey PA (1999) A gender gap in autoimmunity. Science 283:1277–1278

    Article  PubMed  CAS  Google Scholar 

  41. Landers DV, Bronson RA, Pavia CS (1991) Reproductive immunology. In: Stites DP (ed) Basic and clinical immunology. Prentice Hall International Inc, East Norwalk, pp 91–120

    Google Scholar 

  42. Krause PJ, Ingardia CJ, Pontius LT (1987) Host defense during pregnancy: neutrophil chemotaxis and adherence. Am J Obstet Gynecol 157:274–275

    Article  PubMed  CAS  Google Scholar 

  43. Espinosa G, Cervera R, Reverter JC, Tassies D, Font J, Ingelmo M (2002) Vascular involvement in Behçet’s disease. Isr Med Assoc J 4:614–616

    PubMed  Google Scholar 

  44. Krause I, Weinberger A (2002) Vasculo–Behçet’s disease. Isr Med Assoc J 4:636–637

    PubMed  Google Scholar 

  45. Langford CA, Kerr GS (2002) Pregnancy in vasculitis. Curr Opin Rheumatol 14:36–41

    Article  PubMed  Google Scholar 

  46. Belo L, Silva AS, Rocha S et al (2005) Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol 123:46–51

    Article  PubMed  CAS  Google Scholar 

  47. Branch DW (1992) Physiologic adaptations of pregnancy. AmJ Reprod Immunol 28:120–122

    Article  CAS  Google Scholar 

  48. Cetinkaya R, Odabas AR, Gursan N et al (2002) Microscopic polyangiitis in a pregnant woman. South Med J 95:1441–1443

    PubMed  Google Scholar 

  49. Hiyama J, Shiota Y, Marukawa M et al (2000) Churg-Strauss syndrome associated with pregnancy. Intern Med 39:985–990

    Article  PubMed  CAS  Google Scholar 

  50. Lima F, Buchanan N, Froes L et al (1995) Pregnancy in granulomatous vasculitis. Ann Rheum Dis 54:604–606

    Article  PubMed  CAS  Google Scholar 

  51. Del Corso L, De Marco S, Vannini A et al (1993) Takayasu’s arteritis: low corticosteroid dosage and pregnancyda case report. Angiology 44:827–831

    Article  PubMed  Google Scholar 

  52. Nabil H, Zayed A, State O, Badawy A (2012) Pregnancy outcome in women with familial Mediterranean fever. J Obstet Gynaecol 32(8):756–759. doi:10.3109/01443615.2012.698667

    Article  PubMed  CAS  Google Scholar 

  53. Petri M (2003) Immunosuppressive drug use in pregnancy. Autoimmunity 36:51–56

    Article  PubMed  CAS  Google Scholar 

  54. Uribe MO, Gilliot C, Jung G et al (2006) Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinatol 26:252–255

    Article  Google Scholar 

  55. Merlob P, Stahl B, Klinger G (2009) Tetrada of the possible mycophenolate mofetil embryopathy: a review. Reprod Toxicol 28:105–108

    Article  PubMed  CAS  Google Scholar 

  56. Ali YM, Kuriya B, Orozco C, Cush JJ, Keystone EC (2010) Can tumor necrosis factor inhibitors be safely used in pregnancy? J Rheumatol 37:9–17

    Article  PubMed  CAS  Google Scholar 

  57. Roux CH, Brocq O, Breuil V et al (2006) Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-{alpha} therapy. Rheumatology (Oxford) 46(4):695–698

    Article  Google Scholar 

Download references

Acknowledgments

To Dr. De Magnis Angelina for scientific support in description of genital ulcer.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Via Nievo 2, 50129, Florence, Italy

    Maria Elisabetta Coccia

  2. Department of Obstetrics and Gynecology, University of Florence, Largo Brambilla 1, 50129, Florence, Italy

    Tommaso Capezzuoli

Authors
  1. Maria Elisabetta Coccia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tommaso Capezzuoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Elisabetta Coccia .

Editor information

Editors and Affiliations

  1. SOD Patologia Medica, Center for Autoimmune Systemic Diseases, Behçet Center and Lupus Clinic - AOU Careggi, Florence, Italy

    Lorenzo Emmi

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

Coccia, M.E., Capezzuoli, T. (2014). Behçet’s Syndrome and Gynecological Manifestation in Reproductive Age and Pregnancy. In: Emmi, L. (eds) Behçet's Syndrome. Rare Diseases of the Immune System. Springer, Milano. https://doi.org/10.1007/978-88-470-5477-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5477-6_14

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5476-9

  • Online ISBN: 978-88-470-5477-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation